Exchange Announcement • 02 Dec 2025 21:46
Exchange Announcement • 27 Nov 2025 05:29
Exchange Announcement • 07 Nov 2025 22:01
Exchange Announcement • 07 Nov 2025 05:31
Exchange Announcement • 07 Nov 2025 05:07
Search or
𝛼SK
𝛼SKENTITY
MetaVia (MTVA US)
MetaVia (MTVA US)
14
Analysis
Health Care • United States
MetaVia Inc. operates as a clinical-stage biotechnology company. The Company focuses on developing dual oxyntomodulin (OXM) analog agonist for the treatment of obesity and metabolic dysfunction-associated steatohepatitis (MASH). MetaVia serves customers worldwide.
morex